Industry News

Rion Aesthetics, a leading regenerative aesthetics company, has announced its clinical results from a recent cosmetic study utilizing platelet-derived exosome technology to treat aging skin. This study was conducted at Mayo Clinic in Rochester, MN, and principal investigator Saranya Wyles, ...

To extend the upstream production and downstream applications of exosomes, Creative Biolabs collects new strategies and technologies to prompt exosome-based biomolecule delivery, including drugs and vaccines. It’s increasingly recognized that exosomes, a type of nanometer-sized extracellular vesicles, have played a ...

ExThera Medical is pleased to announce that published data from a preliminary European study demonstrating in vitro adsorption of human circulating tumor cells (CTC) has been corroborated..

Carnegie Mellon University has licensed a proprietary platform for bioengineering exosomes for drug delivery to Coya Therapeutics, Inc. Through the...

Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today...

Molecular Stethoscope, a leading precision medicine company pioneering the next-generation cell-free mRNA (cf-mRNA) liquid biopsy, announced publication of the study entitled “Survey of extracellular communication of systemic and organ-specific inflammatory responses through cell free messenger RNA profiling in mice” in eBiomedicine, ...

Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad...

On September 8th at 11AM EDT, Spectradyne will announce the revolutionary new ARC™ particle analyzer. Based on Spectradyne’s proven Microfluidic Resistive Pulse Sensing (MRPS) technology for measuring size and concentration of biological nanoparticles.

New methods and tools for isolation and detection of exosomes are constantly being developed, but it can be difficult to know which to use. Biotium scientists provide detailed protocols for isolating exosomes...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio Inc., a leading supplier...